The MassARRAY® SARS-CoV-2 Variant Panel enables laboratories to detect and discriminate dominant SARS-CoV-2 variants. Our optimized workflow helps laboratories overcome the complex, expensive, and long-turnaround challenges that come with sequencing-based technologies. Available for Research Use Only.
Discover how labs across the world use our core technology to achieve faster decisions and greater productivity in precision medicine.
Identify and differentiate among the UK (B.1.1.7), South Africa (B.1.351), Brazil (P.1), Denmark (Cluster 5) and D614G strains from the Wuhan lineage of SARS-CoV-2. Our optimized workflow helps laboratories overcome the complex, expensive, and long-turnaround challenges that come with sequencing-based technologies…
Learn MoreDr. Martin Stürmer discusses the effects of emerging SARS-CoV-2 variants on diagnostic methods and the clinical utility of detecting and discriminating them. Thomas Alef shares how their clinical lab was able to react to the emergence of new, often more contagious, variants of the virus by rapidly designing a highly multiplexed…
Watch Now